Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Goodwin says it advised Keensight and Bedfont on acquiring coVita
Goodwin said its private equity team advised Keensight Capital and Bedfont Scientific on their acquisition of medical diagnostic equipment company coVita. The firm said the acquisition gives Bedfont a U.S. base for clinical research and localized distribution, training and technical support.
Key points
- Goodwin said Ed Amer in Boston and Jamie Holdoway in London led the cross-border team.Goodwin
- The firm described Keensight as a European growth buyout investor focused on technology and healthcare.Goodwin
- Goodwin said Bedfont designs and manufactures breath analysis medical devices.Goodwin
- The firm identified Bedfont’s NObreath fractional exhaled nitric oxide device among its products.Goodwin